Comparative effectiveness of surgery and radiosurgery for stage I non–small cell lung cancer

Although surgery is the standard treatment for early‐stage non–small cell lung cancer (NSCLC), stereotactic body radiotherapy (SBRT) has been disseminated as an alternative therapy. The comparative mortalities and toxicities of these treatments for patients of different life expectancies are unknown.

[1]  Joe Y. Chang,et al.  Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. , 2014, JAMA surgery.

[2]  Levi I Herman,et al.  Pain is prevalent and persisting in cancer survivors: differential factors across age groups. , 2014, Journal of geriatric oncology.

[3]  H. Wakelee,et al.  Early-stage non-small cell lung cancer: surgery, stereotactic radiosurgery, and individualized adjuvant therapy. , 2014, Seminars in oncology.

[4]  G. Lyman,et al.  Risk factors for in-hospital mortality and prolonged length of stay in older patients with solid tumor malignancies. , 2013, Journal of geriatric oncology.

[5]  Austin Miller,et al.  Temporal trends in outcomes following sublobar and lobar resections for small (≤ 2 cm) non-small cell lung cancers--a Surveillance Epidemiology End Results database analysis. , 2013, The Journal of surgical research.

[6]  M. Edelman,et al.  A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomes. , 2013, Journal of geriatric oncology.

[7]  R. Timmerman,et al.  Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033). , 2013, The Journal of thoracic and cardiovascular surgery.

[8]  C. Gross,et al.  Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer. , 2012, The Annals of thoracic surgery.

[9]  T. Tuttle,et al.  Surgical treatment of lung cancer: predicting postoperative morbidity in the elderly population. , 2012, The Journal of thoracic and cardiovascular surgery.

[10]  S. Swanson,et al.  Extent of lymph node resection does not increase perioperative morbidity and mortality after surgery for stage I lung cancer in the elderly. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[11]  Suresh Senan,et al.  Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. , 2012, International journal of radiation oncology, biology, physics.

[12]  T. Tuttle,et al.  The Long-term Impact of Surgical Complications After Resection of Stage I Nonsmall Cell Lung Cancer: A Population-based Survival Analysis , 2011, Annals of surgery.

[13]  J. Bradley,et al.  Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. , 2010, The Journal of thoracic and cardiovascular surgery.

[14]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[15]  B. Diggs,et al.  The influence of surgeon specialty on outcomes in general thoracic surgery: a national sample 1996 to 2005. , 2009, The Annals of thoracic surgery.

[16]  J. Luketich,et al.  Anatomic segmentectomy for stage I non-small cell lung cancer in the elderly. , 2009, The Annals of thoracic surgery.

[17]  Jan Nyman,et al.  Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  E. Smit,et al.  Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.

[19]  Lech Papiez,et al.  Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. , 2005, International journal of radiation oncology, biology, physics.

[20]  C. Mountain,et al.  Staging classification of lung cancer. A critical evaluation. , 2002, Clinics in chest medicine.

[21]  L V Rubinstein,et al.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1995, The Annals of thoracic surgery.

[22]  S. Shirvani,et al.  Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer. , 2013, Practical radiation oncology.

[23]  C. Steiner,et al.  Comorbidity measures for use with administrative data. , 1998, Medical care.